Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Janssen

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
Gut|February 14, 2018
Gut microbiota modulate T cell trafficking into human colorectal cancerEleonora Cremonesi, Valeria Governa, Jesus Francisco Glaus Garzon, et al.
Nature Metabolism|September 1, 2025
ATF6 activation alters colonic lipid metabolism causing tumour-associated microbial adaptationOlivia I Coleman, Adam Sorbie, Alessandra Riva, et al.
Nature Cancer|January 3, 2024
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantationErik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist, et al.
Cell Host & Microbe|March 12, 2026
Intratumoral microbiota and host genotype cooperatively shape neutrophil cytotoxic functions in colorectal cancerElisa Sorrenti, Valeria Governa, Davide Bressan, et al.
Clinical Colorectal Cancer|May 3, 2021
Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare StudyYannick Eisele, Patrick M Mallea, Biljana Gigic, et al.
Molecular Oncology|January 21, 2017
Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testingWolff Schmiegel, Rodney J Scott, Susan Dooley, et al.
Nature Communications|October 20, 2025
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regenerationSascha Göttert, Erik Thiele Orberg, Kaiji Fan, et al.
Nature Biomedical Engineering|June 4, 2021
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumoursStefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Gut|February 14, 2018
Gut microbiota modulate T cell trafficking into human colorectal cancerEleonora Cremonesi, Valeria Governa, Jesus Francisco Glaus Garzon, et al.
Nature Metabolism|September 1, 2025
ATF6 activation alters colonic lipid metabolism causing tumour-associated microbial adaptationOlivia I Coleman, Adam Sorbie, Alessandra Riva, et al.
Nature Cancer|January 3, 2024
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantationErik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist, et al.
Cell Host & Microbe|March 12, 2026
Intratumoral microbiota and host genotype cooperatively shape neutrophil cytotoxic functions in colorectal cancerElisa Sorrenti, Valeria Governa, Davide Bressan, et al.
Clinical Colorectal Cancer|May 3, 2021
Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare StudyYannick Eisele, Patrick M Mallea, Biljana Gigic, et al.
Molecular Oncology|January 21, 2017
Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testingWolff Schmiegel, Rodney J Scott, Susan Dooley, et al.
Nature Communications|October 20, 2025
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regenerationSascha Göttert, Erik Thiele Orberg, Kaiji Fan, et al.
Nature Biomedical Engineering|June 4, 2021
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumoursStefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, et al.
Pageof 20